ENTITY
Neuren Pharmaceuticals

Neuren Pharmaceuticals (NEU AU)

41
Analysis
Health CareAustralia
Neuren Pharmaceuticals Ltd. is a biopharmaceutical company. The Company researches neurological and metabolic disorders.
more
03 Sep 2023 06:11

Quiddity ASX Sep 23 Rebal: 15 Inflow/Outflow Names; Beware of Short Buildup; US$450mn One-Way

The Inclusion/Exclusion events can be expected to take place at the close of Friday 15th September 2023. I would be Bullish Inflow Names and...

Share
20 Aug 2023 07:19

Index Rebalance & ETF Flow Recap: ASX, NEXT50, MVMVA, MVMVW, Celltrion, Brilliance, KQ150, HSCI

This recap highlights Insights covering Asian index rebalances (announcements/ forecasts/ IPO Fast Entry/ M&A driven changes). We also highlight...

Logo
486 Views
Share
17 Aug 2023 06:04

S&P/​​​​​​​​​ASX Index Rebalance Preview: Potential Adds Have Outperformed

We forecast 26 changes across the ASX50, ASX100, ASX 200 and ASX300 indices at the September rebalance. There is big flow and impact on a lot of...

Logo
552 Views
Share
10 Aug 2023 19:31

Quiddity Leaderboard ASX Sep 23: Potential Surprises and Final Thoughts

I expect ASX 200 and 300 Expected ADDs to outperform the ASX 200 and 300 Expected DELs over the next few weeks since there are many names on both...

Share
bullishWistron Corp
23 Jul 2023 08:41

Index Rebalance & ETF Flow Recap: ASX, SK Telecom, Yuanta ETFs

This recap highlights Insights covering Asian index rebalances (announcements/ forecasts/ IPO Fast Entry/ M&A driven changes). We also highlight...

Logo
487 Views
Share
x